Eton Pharma (ETON) Q3 2025 Earnings Transcript

Thank you, David. Third quarter product revenue was $22.5 million, an increase of 129% year over year and up 19% compared to ...

Innovent and SanegeneBio Announce Phase 1 Clinical Data for IBI3016 Presented at American Heart Association (AHA) 2025 Annual Meeting

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, inc ...
U of T Engineering News

IBET Momentum Fellow Paige McFarlane aims to use microfluidics to design faster, more accurate medical tests

BME PhD student will study point-of-care diagnostics, including how they can account for biomarkers and variations specific ...

Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH ...

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.